Modafinil for multiple sclerosis fatigue: Does it work?

Clinical Neurology and Neurosurgery

Volumn 112, Issue 1, 2010, Pages 29-31

  Littleton, Edward T ^a   Hobart, Jeremy C ^b   Palace, Jacqueline ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

Fatigue; Modafinil; Multiple sclerosis; Outcomes; Sleepiness

Indexed keywords

MODAFINIL;

ADULT; ANOREXIA; ARTICLE; CLINICAL ARTICLE; CONCENTRATION LOSS; CONSTIPATION; DAYTIME SOMNOLENCE; DECISION MAKING; DEPRESSION; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; FATIGUE; FEMALE; HEART PALPITATION; HUMAN; INSOMNIA; INTERVIEW; MALE; MEDICAL AUDIT; MULTIPLE SCLEROSIS; MYALGIA; NAUSEA; OUTCOME ASSESSMENT; PERCEPTION; RETROSPECTIVE STUDY; TREMOR; XEROSTOMIA;

ADULT; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; FATIGUE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RETROSPECTIVE STUDIES; SLEEP STAGES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 71649115690     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2009.09.004     Document Type: Article

References (12)

1. Lobentanz I.S., Asenbaum S., Vass K., Sauter C., Klösch G., Kollegger H., et al. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol Scand 110 (2004) 6-13
2. Broughton R.J., Fleming J.A., George C.F., Hill J.D., Kryger M.H., Moldofsky H., et al. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology 49 2 (1997) 444-451
3. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group. Neurology 2000;54(5):1166-75.
4. Rammohan K.W., Rosenberg J.H., Lynn D.J., Blumenfeld A.M., Pollak C.P., and Nagaraja H.N. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry 72 (2002) 179-183
5. Stankoff B., Waubant E., Confavreux C., Edan G., Debouverie M., Rumbach L., et al. Modafinil for fatigue in MS. A randomized placebo-controlled double-blind study. Neurology 64 (2005) 1139-1143
6. Schwid S.R., Covington M., Segal B.M., and Goodman A.D. Fatigue in multiple sclerosis: current understanding and future directions. J Rehabil Res Dev 39 2 (2002) 211-224
7. Krupp L.B. Fatigue in multiple sclerosis: definition, pathophysiology and treatment. CNS Drugs 17 4 (2003) 225-234
8. Flachenecker P., Kumpfel T., Kallmann B., Gottschalk M., Grauer O., Rieckmann P., et al. Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler 8 6 (2002) 523-526
9. Rothwell P.M. External validity of randomised controlled trials: to whom do the results of this trial apply?. Lancet 365 (2005) 82-93
10. Taphoorn M.J., van Someren E., Snoek F.J., Strijers R.L., Swaab D.F., Visscher F., et al. Fatigue, sleep disturbances and circadian rhythm in multiple sclerosis. J Neurol 240 7 (1993) 446-448
11. Attarian H.P., Brown K.M., Duntley S.P., Carter J.D., and Cross A.H. The relationship of sleep disturbances and fatigue in multiple sclerosis. Arch Neurol 61 4 (2004) 525-528
12. Freal J.E., Kraft G.H., and Coryell J.K. Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil 54 (1984) 135-138